Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
NCT05689996 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2023-01-19
Summary
To compare the therapeutic effect of ozone-based eye drops as an adjuvant therapy to that of the conventional topical antimicrobial agents in patients with microbial keratitis . The therapeutic response will be evaluated with clinical examination follow up .
Conditions
- Keratitis
Interventions
- DRUG
-
Ozone-Based Agent
Ozone-based eye drops as adjuvant therapy in microbial keratitis
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2023-04-30
- Completion
- 2023-05-01
More Related Trials
-
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
NCT06451172 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Change in Ocular Flora Resistance From Repeated Topical Antibiotic Use
NCT01181713 ·Status: COMPLETED
-
Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs
NCT02819232 ·Status: COMPLETED ·Phase: NA
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Matrix Therapy And Bacterial Keratitis
NCT02016989 ·Status: UNKNOWN ·Phase: NA
-
Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis
NCT04451239 ·Status: UNKNOWN ·Phase: NA
-
Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers
NCT00356772 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
NCT00383396 ·Status: COMPLETED ·Phase: PHASE4
-
PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects
NCT03586908 ·Status: COMPLETED ·Phase: PHASE1
-
Exploratory Study of OPC-12759 Ophthalmic Suspension
NCT01493180 ·Status: COMPLETED ·Phase: PHASE2
-
Tear Concentrations and Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers
NCT03252067 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis
NCT05720715 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults
NCT05969236 ·Status: COMPLETED ·Phase: PHASE1
-
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)
NCT01269658 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
NCT01089608 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period
NCT00892970 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)
NCT00894530 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
NCT03920215 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Confirmatory Study of OPC-12759 Ophthalmic Solution
NCT01660256 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
NCT03636061 ·Status: COMPLETED ·Phase: PHASE2
-
Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment of Dry Eye Disease
NCT07298811 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
NCT05353101 ·Status: COMPLETED ·Phase: PHASE1
-
Low Dose Doxycycline in the Treatment of Corneal Burn
NCT01886560 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Autologous Serum Eye Drops in Dry Eye Syndrome
NCT07295691 ·Status: RECRUITING ·Phase: NA
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2